Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn
暂无分享,去创建一个
A. Stark | D. Wessel | E. Allred | S. Kourembanas | H. Christou | L. V. Van Marter | J. Thompson | John E. Thompson | J. Kane | Helen Christou | Linda J. Van Marter
[1] J. Kattwinkel,et al. Inhaled Nitric Oxide for the Early Treatment of Persistent Pulmonary Hypertension of the Term Newborn: A Randomized, Double-Masked, Placebo-Controlled, Dose-Response, Multicenter Study , 1998, Pediatrics.
[2] A. Stark,et al. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. , 1997, Pediatrics.
[3] G. Redding,et al. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn , 1997 .
[4] A. Stark,et al. Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5'-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension. , 1997, The Journal of pediatrics.
[5] Jesse D. Roberts,et al. Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn , 1997 .
[6] Cook,et al. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. , 1997, The New England journal of medicine.
[7] D. Shannon,et al. Whole Body Arginine Metabolism and Nitric Oxide Synthesis in Newborns with Persistent Pulmonary Hypertension , 1995, Pediatric Research.
[8] S. Abman,et al. Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. , 1994, The Journal of pediatrics.
[9] P. Hickey,et al. Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension , 1994, Critical care medicine.
[10] J. Arnold,et al. Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation. , 1994, The Annals of thoracic surgery.
[11] R. Trifiletti,et al. Arginine deficiency accompanies persistent pulmonary hypertension of the newborn. , 1994, Biology of the neonate.
[12] D. Wessel,et al. Use of Inhaled Nitric Oxide and Acetlcholine in the Evaluation of Pulmonary Hypertension and Endothelial Function After Cardiopulmonary Bypass , 1993, Circulation.
[13] E. Shaffer,et al. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. , 1993, The Journal of pediatrics.
[14] R. Rossaint,et al. Inhaled nitric oxide for the adult respiratory distress syndrome. , 1993, New England Journal of Medicine.
[15] E. Shaffer,et al. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn , 1992, The Lancet.
[16] Jesse D. Roberts,et al. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn , 1992, The Lancet.
[17] D. Katayose,et al. Modulatory role of EDRF in hypoxic contraction of isolated porcine pulmonary arteries. , 1992, The American journal of physiology.
[18] T. Higenbottam,et al. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension , 1991, The Lancet.
[19] J. Wain,et al. Inhaled Nitric Oxide: A Selective Pulmonary Vasodilator Reversing Hypoxic Pulmonary Vasoconstriction , 1991, Circulation.
[20] S. Moncada,et al. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.
[21] L. Ignarro,et al. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. , 1986, The Journal of pharmacology and experimental therapeutics.